Lasa Supergenerics Ltd
NSE: LASA BSE: 540702
₹4.44
-0.23 (4.93%)
Fri, 06 Nov 2026, 08:25 pm
Market Cap (in Cr)23.95
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KLasa Supergenerics Balance Sheet
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Interest expense on debt | -116.77M | -113.44M | -120.21M | -81.04M | -19.63M | -403.00K | -41.61M | -19.32M | -26.92M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 2.28B | 2.87B | 2.58B | 2.32B | 2.08B | 2.09B | 1.64B | 1.51B | 1.02B |
| Total current assets | 794.07M | 1.09B | 858.37M | 758.74M | 643.23M | 662.98M | 392.20M | 378.89M | 325.14M |
| Cash and short term investments | 11.62M | 26.35M | 26.85M | 60.62M | 44.00M | 172.17M | 23.90M | 14.96M | 7.90M |
| Cash & equivalents | 1.42M | 4.97M | 26.85M | 60.62M | 44.00M | 172.17M | 23.90M | 6.08M | 2.75M |
| Short term investments | 10.20M | 21.38M | 0 | 0 | 0 | 0 | 0 | 8.88M | 5.15M |
| Total receivables, net | 349.70M | 422.12M | 289.33M | 207.03M | 148.23M | 186.08M | 25.28M | 36.37M | 15.42M |
| Accounts receivable - trade, net | 349.70M | 421.51M | 288.79M | 206.48M | 147.68M | 185.58M | 24.78M | 35.87M | 14.92M |
| Other receivables | 0 | 609.00K | 535.00K | 546.00K | 552.00K | 500.00K | 500.00K | 500.00K | 500.00K |
| Total inventory | 348.41M | 514.32M | 424.25M | 263.05M | 430.92M | 278.18M | 296.24M | 190.43M | 244.97M |
| Other current assets, total | 83.77M | 127.51M | 117.08M | 27.56M | 19.98M | 1.61M | 952.00K | 137.13M | 56.85M |
| Total non-current assets | 1.49B | 1.78B | 1.73B | 1.56B | 1.44B | 1.43B | 1.25B | 1.13B | 690.18M |
| Long term investments | 4.99M | 7.19M | 7.37M | 7.51M | 5.85M | 3.84M | 3.87M | 0 | 0 |
| Note receivable - long term | 4.98M | 7.18M | 7.37M | 7.51M | 5.85M | 6.13M | — | — | — |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other investments | 10.00K | 10.00K | 0 | 0 | 0 | 3.84M | 3.87M | 0 | 0 |
| Net property/plant/equipment | 1.42B | 1.71B | 1.63B | 1.46B | 1.38B | 1.25B | 927.79M | 863.28M | 483.42M |
| Gross property/plant/equipment | 1.55B | 2.02B | 2.13B | 2.13B | 2.20B | 2.20B | 1.99B | 1.99B | 942.65M |
| Deferred tax assets | — | — | 30.20M | 31.74M | — | — | — | — | — |
| Net intangible assets | 61.49M | 62.45M | 62.81M | 62.33M | 54.47M | 167.62M | 308.24M | 259.42M | 198.94M |
| Goodwill, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 116.81M | 110.67M |
| Other intangibles, net | 61.49M | 62.45M | 62.81M | 62.33M | 54.47M | 167.62M | 308.24M | 142.60M | 88.27M |
| Other long term assets, total | 0 | 0 | 0 | 0 | 0 | 6.33M | 6.44M | 7.10M | 7.83M |
| Short term debt | 351.02M | 463.91M | 388.73M | 342.69M | 194.63M | 201.71M | 217.70M | 220.76M | 21.27M |
| Current portion of LT debt and capital leases | 119.17M | 165.61M | 158.70M | 139.31M | 194.63M | 201.71M | 217.70M | 0 | 0 |
| Short term debt excl. current portion of LT debt | 231.85M | 298.30M | 230.03M | 203.38M | 0 | 0 | 0 | 220.76M | 21.27M |
| Accounts payable | 253.84M | 479.35M | 596.74M | 337.31M | 127.22M | 169.10M | 94.27M | 140.54M | 102.17M |
| Income tax payable | 20.69M | 29.35M | 0 | 9.08M | 19.75M | 0 | — | — | — |
| Long term debt | 785.89M | 548.12M | 457.22M | 141.42M | 0 | 0 | 0 | 0 | 0 |
| Long term debt excl. lease liabilities | 785.89M | 548.12M | 457.22M | 141.42M | 0 | 0 | 0 | 0 | 0 |
| Total equity | 754.94M | 1.17B | 1.05B | 1.41B | 1.59B | 1.58B | 1.18B | 966.76M | 837.13M |
| Shareholders' equity | 754.94M | 1.17B | 1.05B | 1.41B | 1.59B | 1.58B | 1.18B | 966.76M | 837.13M |
| Common equity, total | 754.94M | 1.17B | 1.05B | 1.41B | 1.59B | 1.58B | 1.18B | 966.76M | 837.13M |
| Other common equity | 761.15M | 555.37M | 555.37M | 555.37M | 555.37M | 515.77M | 515.77M | 515.77M | 515.77M |
| Total debt | 1.14B | 1.01B | 845.96M | 484.12M | 194.63M | 201.71M | 217.70M | 220.76M | 21.27M |
| Net debt | 1.13B | 985.68M | 819.11M | 423.50M | 150.63M | 29.54M | 193.80M | 205.80M | 13.37M |
| Change in accounts receivable | -140.07M | -74.57M | 132.72M | 82.16M | 60.46M | -37.52M | 160.68M | -75.60M | 20.95M |
| Change in taxes payable | — | — | — | — | — | — | — | — | — |
| Change in accounts payable | -65.16M | 225.51M | 117.39M | -259.44M | -210.09M | 32.11M | -74.83M | 46.26M | -38.36M |
| Change in other assets/liabilities | 120.16M | -49.77M | -25.36M | -35.79M | -173.00K | -16.32M | 30.03M | 76.99M | -47.86M |
| Sale of fixed assets & businesses | 0 | 0 | 0 | 0 | 0 | 25.84M | 48.33M | 0 | 77.64M |
| Purchase/sale of investments, net | 0 | 0 | -1.26M | -12.30M | 29.32M | -55.91M | 45.57M | 10.90M | 3.73M |
| Sale/maturity of investments | 0 | 0 | 0 | 0 | 29.32M | — | 45.57M | 10.90M | 3.73M |
| Purchase of investments | 0 | 0 | -1.26M | -12.30M | 0 | -55.91M | 0 | 0 | 0 |
| Other investing cash flow items, total | 0 | 0 | 0 | 1.00K | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of debt, net | 116.29M | -148.83M | -213.75M | -342.45M | -344.80M | 0 | 0 | 3.06M | -52.53M |
| Issuance/retirement of long term debt | 0 | 0 | -145.47M | -315.80M | -141.42M | 0 | 0 | 0 | 0 |
| Issuance/retirement of short term debt | 54.45M | 55.28M | -68.27M | -26.65M | -203.38M | 0 | 0 | 3.06M | -52.53M |
| Issuance/retirement of other debt | 61.83M | -204.10M | — | — | — | — | — | — | — |
| Total cash dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other financing cash flow items, total | 0 | 0 | 9.00K | 146.92M | 0 | 0 | 0 | 0 | 5.33M |
